
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic variation inTERTmodifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Stephan Buch, Hamish Innes, Philipp Lutz, et al.
Gut (2022) Vol. 72, Iss. 2, pp. 381-391
Open Access | Times Cited: 33
Stephan Buch, Hamish Innes, Philipp Lutz, et al.
Gut (2022) Vol. 72, Iss. 2, pp. 381-391
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 108
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 108
The exposome and liver disease - how environmental factors affect liver health
Robert Barouki, Michel Samson, Étienne Blanc, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 492-505
Open Access | Times Cited: 70
Robert Barouki, Michel Samson, Étienne Blanc, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 492-505
Open Access | Times Cited: 70
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 24
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 24
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
Manal M. Hassan, Donghui Li, Younghun Han, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 87-101
Open Access | Times Cited: 8
Manal M. Hassan, Donghui Li, Younghun Han, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 87-101
Open Access | Times Cited: 8
Alcohol consumption and hepatocellular carcinoma: novel insights from a prospective cohort study and nonlinear Mendelian randomization analysis
Zhenqiu Liu, Ci Song, Chen Suo, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Zhenqiu Liu, Ci Song, Chen Suo, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer
Ruozhu Yang, Yi Han, Xinyu Guan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Ruozhu Yang, Yi Han, Xinyu Guan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients
Qiuling Lin, Moqin Qiu, Xueyan Wei, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1599-1611
Closed Access | Times Cited: 11
Qiuling Lin, Moqin Qiu, Xueyan Wei, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1599-1611
Closed Access | Times Cited: 11
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology
Jialing Sun, Mengqing Ma, Xin Zhong, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117985-117985
Closed Access | Times Cited: 3
Jialing Sun, Mengqing Ma, Xin Zhong, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117985-117985
Closed Access | Times Cited: 3
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease
David E. Kaplan, Craig C. Teerlink, Tae‐Hwi Schwantes‐An, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 3
David E. Kaplan, Craig C. Teerlink, Tae‐Hwi Schwantes‐An, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 3
Differences between hepatocellular carcinoma caused by alcohol and other aetiologies
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2024)
Open Access | Times Cited: 2
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2024)
Open Access | Times Cited: 2
Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study
Chenglei Yang, Xi Wu, Siyu Chen, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9937-9944
Open Access | Times Cited: 6
Chenglei Yang, Xi Wu, Siyu Chen, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9937-9944
Open Access | Times Cited: 6
The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma
Hamish Innes, Marsha Y. Morgan, Jochen Hampe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 623-631
Open Access | Times Cited: 6
Hamish Innes, Marsha Y. Morgan, Jochen Hampe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 623-631
Open Access | Times Cited: 6
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
Franziska Schmalz, Janett Fischer, Hamish Innes, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100684-100684
Open Access | Times Cited: 5
Franziska Schmalz, Janett Fischer, Hamish Innes, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100684-100684
Open Access | Times Cited: 5
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma
Mete Ucdal
Hepatology forum/Hepatology forum (Online) (2024), pp. 150-160
Open Access | Times Cited: 1
Mete Ucdal
Hepatology forum/Hepatology forum (Online) (2024), pp. 150-160
Open Access | Times Cited: 1
PNPLA3 in Alcohol‐Related Liver Disease
Clélia Galvanin, Stephan Buch, Pierre Nahon, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 1
Clélia Galvanin, Stephan Buch, Pierre Nahon, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 1
Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients
Hans Dieter Nischalke, Franziska Schmalz, Stephan Buch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15353-15353
Open Access | Times Cited: 4
Hans Dieter Nischalke, Franziska Schmalz, Stephan Buch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15353-15353
Open Access | Times Cited: 4
Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring
Roberto Piciotti, Miriam Longo, Adele Agresta, et al.
Hepatoma Research (2022) Vol. 8, pp. 37-37
Open Access | Times Cited: 4
Roberto Piciotti, Miriam Longo, Adele Agresta, et al.
Hepatoma Research (2022) Vol. 8, pp. 37-37
Open Access | Times Cited: 4
enHanCCing knowledge of genetic factors in primary liver tumor
Jill Koshiol, Marcin Krawczyk
Hepatology (2024) Vol. 80, Iss. 1, pp. 11-13
Open Access
Jill Koshiol, Marcin Krawczyk
Hepatology (2024) Vol. 80, Iss. 1, pp. 11-13
Open Access
Single Nucleotide Polymorphisms Related to Telomere Length Predispose for Coronary Heart Disease in Chinese Han Population
Hanfang Liu, Xuemin Xian, Changxi Li, et al.
Research Square (Research Square) (2024)
Open Access
Hanfang Liu, Xuemin Xian, Changxi Li, et al.
Research Square (Research Square) (2024)
Open Access
Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era
Ugo Testa
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 9, pp. 803-827
Open Access
Ugo Testa
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 9, pp. 803-827
Open Access
Association between human telomerase reverse transcriptase (hTERT) MNS16A polymorphism and risk of breast cancer
Seyede Mehrana Salehi-Reyhani, Mostafa Saadat
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Seyede Mehrana Salehi-Reyhani, Mostafa Saadat
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study
Hamish Innes, Stephan Buch, Timothy J. Kendall, et al.
Liver International (2024)
Open Access
Hamish Innes, Stephan Buch, Timothy J. Kendall, et al.
Liver International (2024)
Open Access